Simplivia at 3rd Israeli Oncology Pharmacists Conference

Simplivia highlighted its leading Chemfort™ CSTD at the 2022 Israeli Oncology Pharmacists Conference.

March 05, 2022

Simplivia™’s Chemfort™ in Focus

Simplivia recently participated in the 3rd Israeli Oncology Pharmacists Conference, held on March 3rd, 2022 in Herzlia, Israel. The conference was attended by over 60 pharmacists, who participated in a full day of seminars and exhibitions related to oncology pharmacy in Israel.

At the conference, Simplivia presented its Chemfort™ closed system drug-transfer device product family. Chemfort™ reduces the risk of exposure to hazardous drugs, and provides oncology pharmacists with safety and confidence when handling hazardous drugs.